Cargando…

Acetylsalicylic acid use is associated with improved survival in bacteremic pneumococcal pneumonia: A long‐term nationwide study

BACKGROUND: Pneumonia is commonly caused by Streptococcus pneumoniae (pneumococcus) and associated with subsequent cardiovascular complications and increased mortality. Potential short‐term survival benefits conferred by acetylsalicylic acid (ASA) use in pneumonia remain controversial, and long‐term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rögnvaldsson, Kristján G., Bjarnason, Agnar, Kristinsson, Karl, Bragason, Hörður T., Erlendsdóttir, Helga, Þorgeirsson, Guðmundur, Gottfreðsson, Magnús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543431/ https://www.ncbi.nlm.nih.gov/pubmed/35315156 http://dx.doi.org/10.1111/joim.13485

Ejemplares similares

Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study
por: Bjarnason, Agnar, et al.
Publicado: (2015)

Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study
por: Bjarnason, Agnar, et al.
Publicado: (2018)

Epididymitis associated with bacteremic pneumococcal pneumonia
por: Berlinrut, Ilan, et al.
Publicado: (2021)

Bacteremic pneumococcal pneumonia: arrhythmogenic disease
por: Fernandez, Leyre Serrano, et al.
Publicado: (2022)

Macrolide Resistance in Adults with Bacteremic Pneumococcal Pneumonia
por: Metlay, Joshua P., et al.
Publicado: (2006)

Severity of Influenza A 2009 (H1N1) Pneumonia Is Underestimated by Routine Prediction Rules. Results from a Prospective, Population-Based Study
por: Bjarnason, Agnar, et al.
Publicado: (2012)

Increase in tympanostomy tube placements despite pneumococcal vaccination, a population‐based study
por: Eythorsson, Elias, et al.
Publicado: (2019)

Neisseria meningitidis Sequence Type and Risk for Death, Iceland
por: Gottfreðsson, Magnús, et al.
Publicado: (2006)

Impact of the 10-valent pneumococcal conjugate vaccine on antimicrobial prescriptions in young children: a whole population study
por: Eythorsson, Elias, et al.
Publicado: (2018)

Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland
por: Hjálmarsdóttir, Martha Á., et al.
Publicado: (2020)

The Effect of Macrolides on Mortality in Bacteremic Pneumococcal Pneumonia: A Retrospective, Nationwide Cohort Study, Israel, 2009–2017
por: Chowers, Michal, et al.
Publicado: (2022)

Empyema and bacteremic pneumococcal pneumonia in children under five years of age,
por: Cardoso, Maria Regina Alves, et al.
Publicado: (2014)

Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland—A population-based time series analysis
por: Eythorsson, Elias, et al.
Publicado: (2021)

Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines
por: Benfield, Thomas, et al.
Publicado: (2013)

Native joint infections in Iceland 2003–2017: an increase in postarthroscopic infections
por: Gunnlaugsdóttir, Signý Lea, et al.
Publicado: (2022)

Utility of oropharyngeal real-time PCR for S. pneumoniae and H. influenzae for diagnosis of pneumonia in adults
por: Bjarnason, A., et al.
Publicado: (2016)

Impact of the new membrane-targeting lipoglycopeptide antibiotic MCC5145 on the treatment of bacteremic pneumococcal pneumonia in mice
por: Ogunniyi, Abiodun D., et al.
Publicado: (2023)

A Leukocyte Score to Improve Clinical Outcome Predictions in Bacteremic Pneumococcal Pneumonia in Adults
por: Blot, Mathieu, et al.
Publicado: (2014)

More than Meets the Eye: Bacteremic Pneumococcal Pneumonia as the Initial Presentation of Multiple Myeloma
por: Jautz, Jonas, et al.
Publicado: (2021)

1460. Community-Acquired Bacteremic Pneumonia in Post-pneumococcal Vaccination Era in a Pediatric Hospital
por: Gentile, Angela, et al.
Publicado: (2018)

Moraxella catarrhalis bacteremic pneumonia
por: Anezaki, Hiroki, et al.
Publicado: (2020)

The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
por: Sveinsdóttir, Hildigunnur, et al.
Publicado: (2019)

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2017)

327. Comparison of Clinical Outcome, Causative Serotypes, and Antimicrobial Susceptibilities Between Pneumococcal Meningitis and Pneumococcal Bacteremic Pneumonia in Adult Patients in the Republic of Korea
por: Kim, Jeong Yeon, et al.
Publicado: (2018)

Prognostic factors associated with mortality and major in-hospital complications in patients with bacteremic pneumococcal pneumonia: Population-based study
por: Beatty, Jessica A., et al.
Publicado: (2016)

1475. Impact of a Routine Infant PCV Program on the Serotype Distribution of Episodes of Invasive Pneumococcal Disease (IPD) and Non-bacteremic Pneumococcal Pneumonia in Adults
por: McGeer, Allison
Publicado: (2020)

Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland
por: Quirk, Sigríður J., et al.
Publicado: (2019)

Clinical Characteristics and Prognosis of Hospital-Acquired Klebsiella pneumoniae Bacteremic Pneumonia versus Escherichia coli Bacteremic Pneumonia: A Retrospective Comparative Study
por: Li, Fuxing, et al.
Publicado: (2023)

1474. Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017
por: Gierke, Ryan, et al.
Publicado: (2020)

Clinical and Microbiological Characteristics of Bacteremic Pneumonia Caused by Klebsiella pneumoniae
por: Chen, I-Ren, et al.
Publicado: (2022)

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study
por: Ruiz, Luis A., et al.
Publicado: (2017)

Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile
por: Fica, Alberto, et al.
Publicado: (2013)

Bacteremic and non-bacteremic pneumonia caused by Acinetobacter baumannii in ICUs of South China: A Clinical and Microbiological Study
por: Tan, Yunfang, et al.
Publicado: (2017)

Bacteremic nosocomial pneumonia cases from the ATTAIN studies
por: Rubinstein, E, et al.
Publicado: (2010)

Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia
por: Khasawneh, Faisal A, et al.
Publicado: (2014)

Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland
por: Hjálmarsdóttir, Martha Á., et al.
Publicado: (2017)

Putatively novel serotypes and the potential for reduced vaccine effectiveness: capsular locus diversity revealed among 5405 pneumococcal genomes
por: van Tonder, Andries J., et al.
Publicado: (2016)

Acute bacteremic pneumonia due to melioidosis developing in the intensive care setting
por: Zainal Abidin, Huda, et al.
Publicado: (2017)

Improved survival with continuation of statins in bacteremic patients
por: Pawar, Ajinkya M, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sjcoao4mh6dhf9g5qd2b9jbvhq